80274-28-8

Basic information

• Product Name: 1-cyclopropylcarbonyl-4-(3-(4'-fluorophenyl)-6-fluoro-1-indanyl)piperazine
• CAS NO: 80274-28-8
• Molecular Weight: 382.453
• Mol File: 80274-28-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-cyclopropylcarbonyl-4-(3-(4'-fluorophenyl)-6-fluoro-1-indanyl)piperazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-cyclopropylcarbonyl-4-(3-(4'-fluorophenyl)-6-fluoro-1-indanyl)piperazine(80274-28-8)
• EPA Substance Registry System: 1-cyclopropylcarbonyl-4-(3-(4'-fluorophenyl)-6-fluoro-1-indanyl)piperazine(80274-28-8)

Safety Data

• Hazardous Substances Data: 80274-28-8(Hazardous Substances Data)

Upstream product

• 4023-34-1 cyclopropanecarboxylic acid chloride 
• 344551-41-3 1-<6-fluoro-3-(4-fluorophenyl)indan-1-yl>piperazine 
• 80272-38-4 3-(4-fluorophenyl)-6-(trifluoromethyl)indan-1-one 
• 85118-24-7 2-bromo-4-(trifluoromethyl)benzaldehyde 
• 80272-85-1 3-(4-fluorophenyl)-6-(trifluoromethyl)indan-1-ol 
• 85118-26-9 1-chloro-3-(4-fluorophenyl)-6-(trifluoromethyl)indan 
• 85118-34-9 ethyl 3-<2-bromo-4-(trifluoromethyl)phenyl>-2-cyano-2-propenoate 
• 80272-16-8 3-<2-bromo-4-(trifluoromethyl)phenyl>-3-(4-fluorophenyl)propanoic acid 
• 85663-11-2 ethyl 3-<2-bromo-4-(trifluoromethyl)phenyl>-2-cyano-3-(4-fluorophenyl)propanoate 

Downstream Products

• 85663-28-1 cis-1-(cyclopropylmethyl)-4-<6-fluoro-3-(4-fluorophenyl)indan-1-yl>piperazine 
• 85663-27-0 trans-1-(cyclopropylmethyl)-4-<6-fluoro-3-(4-fluorophenyl)indan-1-yl>piperazine 

Relevant articles and documents

Indane derivatives, pharmaceutical compositions thereof and method of preparation

The present invention relates to novel 1-piperazino-3-phenyl-indane derivatives which have pronounced psychopharmacological activity such as neuroleptic activity, analgesic activity, antidepressant activity and, at the same time, a low degree of undesired side-effects, methods for the preparation of said indane derivatives, pharmaceutical compositions containing same, and methods for the treatment of psychic disorders, such as psychoses and depressions and pain, by administering a therapeutically active amount of one of said derivatives to a living animal body, including human beings.